About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Monogram Technologies Inc. - Common Stock (NQ: MGRM )

1.970 -0.010 (-0.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,231
Open 1.980
Bid (Size) 1.930 (2)
Ask (Size) 2.100 (16)
Prev. Close 1.980
Today's Range 1.960 - 2.040
52wk Range 1.530 - 4.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Monogram Technologies Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE

Performance

YTD
-45.13%
-45.13%
1 Month
-17.23%
-17.23%
3 Month
-42.73%
-42.73%
6 Month
-3.43%
-3.43%
1 Year
-36.04%
-36.04%

More News

Read More
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Via ACCESSWIRE
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Via ACCESSWIRE
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Via ACCESSWIRE
Monogram Technologies Receives FDA Response for mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Via ACCESSWIRE
Monogram Technologies Announces Preferred Stock Dividends
Via ACCESSWIRE
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Via ACCESSWIRE
Monogram Orthopedics (NASDAQ: MGRM) Readies Commercialization Of Next-Gen Surgical Robot
Via News Direct
Monogram Orthopedics (NASDAQ: MGRM) Lands Key Clinical Trial Partnership With India’s Leading Orthopedic Hospital Group To Advance Its Surgical Robot Tech
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
Via ACCESSWIRE
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Via ACCESSWIRE
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
Via ACCESSWIRE
MGRM Stock Earnings: Monogram Technologies Misses EPS for Q2 2024
Via InvestorPlace
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE
Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants
Via ACCESSWIRE
MGRM Stock Earnings: Monogram Orthopaedics Beats EPS for Q1 2024
Via InvestorPlace
Why Pure Storage Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
Via ACCESSWIRE
Technology Is Enabling Remote Work In More And More Fields – Could Surgery Be Next? Surgical Robot Maker Monogram Orthopedics (NASDAQ: MGRM) Believes So
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.